Literature DB >> 20578900

Drugs affecting thyroid function.

Giuseppe Barbesino1.   

Abstract

INTRODUCTION: Over the years, several drugs used in the treatment of nonthyroidal conditions have been shown to affect thyroid function. As novel drugs are introduced, novel interactions are described. The aim of this review is to summarize clinically relevant thyroidal side effects of drugs used for nonthyroidal conditions. Special focus is given to recent developments and to drugs with the largest clinical relevance.
SUMMARY: Thyrosine kinase inhibitors are novel drugs used in the treatment of several neoplasias, including thyroid cancer. Thyroidal side effects are being increasingly detected with these drugs. Some drugs in this category affect thyroid hormone metabolism and therefore only affect patients on thyroid replacement. Others affect the thyroid directly profoundly, causing primary hypothyroidism. Immune modulators used in infectious, inflammatory, and neoplastic conditions also cause hyper- and hypothyroidism, through poorly understood immune or nonimmune mechanisms. The effects of amiodarone on the thyroid have been long recognized. However, given the complexity of these effects, several areas in this field remain problematic, such as the identification of subtypes of hyperthyroidism and the best treatment strategies. Lithium also has important antithyroid effects and it is a commonly prescribed medication. Its antithyroid effects may have clinical utility in selected clinical situations. Other drugs known to affect thyroid hormone absorption, metabolism, and transport are also briefly reviewed.
CONCLUSIONS: Several drugs are known to alter thyroid function as a side effect of their primary pharmacological action. Some of these effects have been recognized for decades, but novel thyroid-drug interactions are being recognized as new drugs are developed. It is important for the clinician to be familiar with thyroid-drug interactions, as enhanced surveillance may be necessary in patients undergoing therapies known to affect thyroid function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578900     DOI: 10.1089/thy.2010.1635

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  27 in total

1.  The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.

Authors:  L Tomisti; C Urbani; G Rossi; F Latrofa; C Sardella; L Manetti; I Lupi; C Marcocci; L Bartalena; O Curzio; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2016-01-13       Impact factor: 4.256

2.  Images in endocrine pathology: thyrotoxicosis associated with destructive thyroiditis.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

3.  Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice.

Authors:  Gianluca Trifirò; Fabrizio Parrino; Janet Sultana; Francesco Giorgianni; Carmen Ferrajolo; Elisa Bianchini; Gerardo Medea; Salvatore Benvenga; Iacopo Cricelli; Claudio Cricelli; Francesco Lapi
Journal:  Clin Drug Investig       Date:  2015-03       Impact factor: 2.859

4.  Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals.

Authors:  Shakila Sabir; Muhammad Furqan Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-22       Impact factor: 4.223

Review 5.  A review of the evidence for and against increased mortality in hypothyroidism.

Authors:  Marianne Thvilum; Frans Brandt; Thomas H Brix; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2012-03-06       Impact factor: 43.330

6.  Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Alessandro Antonelli
Journal:  Endocrine       Date:  2015-12-31       Impact factor: 3.633

7.  The evaluation of function and the ultrasonographic picture of thyroid in children treated for medulloblastoma.

Authors:  G Sobol; K Musioł; M Kalina; B Kalina-Faska; A Mizia-Malarz; K Ficek; M Mandera; H Woś; E Małecka-Tendera
Journal:  Childs Nerv Syst       Date:  2011-11-12       Impact factor: 1.475

8.  A thyroid peroxidase (TPO) mutation in dogs reveals a canid-specific gene structure.

Authors:  John C Fyfe; Mary Lynch; Jayme Olsen; Eric Louёr
Journal:  Mamm Genome       Date:  2012-12-08       Impact factor: 2.957

9.  Post-acute effectiveness of lithium in pediatric bipolar I disorder.

Authors:  Robert L Findling; Vivian Kafantaris; Mani Pavuluri; Nora K McNamara; Jean A Frazier; Linmarie Sikich; Robert Kowatch; Brieana M Rowles; Traci E Clemons; Perdita Taylor-Zapata
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03       Impact factor: 2.576

10.  The association of thyroid stimulation hormone levels with incident ischemic heart disease, incident stroke, and all-cause mortality.

Authors:  Line Tang Møllehave; Tea Skaaby; Allan Linneberg; Nils Knudsen; Torben Jørgensen; Betina Heinsbæk Thuesen
Journal:  Endocrine       Date:  2020-02-10       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.